Inhibition of the Mevalonate Pathway Targets Neuroblastoma Stem Cells
Treatment with mevalonate pathway inhibitors leads to reduced neuroblastoma cancer stem cell function through reductions in protein geranylgeranylation.
Authors
- Jeffrey D. Neighbors (ORCID: https://orcid.org/0000-0002-0698-4181)
- Michelle V. Green
- J. Reed (ORCID: https://orcid.org/0000-0001-6477-0168)
- Christina E. Zielinski (ORCID: https://orcid.org/0000-0002-8184-0858)
Institutions
- Penn State Milton S. Hershey Medical Center (US)
- Texas A&M University (US)
Publication Details
- Journal
- Pharmacology
- Published
- 2025-12-13
- DOI
- https://doi.org/10.1159/000549949
- Primary Topic
- Cancer, Lipids, and Metabolism
- Type
- article
- Field-Weighted Citation Impact
- 0.00